Trial NCT00760929

View at ClinicalTrials.gov 
Org. Study IDs: NO21160
Secondary IDs: 2008-001736-12

Last trial update was posted on 2021-01-05

MeSH Interventions

Antibodies, Monoclonal Erlotinib Hydrochloride

MeSH Conditions

Carcinoma, Non-Small-Cell Lung Lung Neoplasms

Other Conditions

Non-Squamous Non-Small Cell Lung Cancer

Stopping Reasons

The study was terminated due to the termination of the clinical development program.

Limitations And Caveats

Development of the study drug R1570 was discontinued based on the available clinical data and the large number of molecules targeting the pathway. Not all efficacy parameters described in the protocol were assessed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID